Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

NCT04600284 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: AD-2101
DRUG: AD-2102
DRUG: AD-2101 + AD-2102

Sponsor

Addpharma Inc.